Diagnotes enables mobile capability of electronic health records
Indianapolis, May 6, 2013 – BioCrossroads Indiana Seed Fund II has made an investment in Diagnotes, an Indianapolis-based health IT company focusing on bringing a comprehensive communications system to on-call healthcare providers through a mobile application. The Indiana Seed Fund II is an $8.25 million early-stage fund focused on identifying, creating and developing the next generation of leading Indiana-based life sciences companies.
“The investment in this technology further drives the meaningful use of electronic health information by providing critical patient information when it’s needed to an increasingly mobile care provider,” said David L. Johnson, President and CEO of BioCrossroads. “Diagnotes and its technology further establish Indiana as a hotbed of HIT innovation and application. This promising company is a local bright star in our growing and important sector of life sciences.”
Diagnotes mobile clinical communication system, the first of its kind, automates and streamlines the workflow of on-call providers by delivering secure patient information straight to a clinician’s smartphone. The technology enables immediate documentation of patient encounters and provider follow up furthering meaningful use of patient data.
“There is a growing need to incorporate technologies that securely facilitate the transfer of vital healthcare information to clinicians,” said David Wortman, Chairman and CEO of Diagnotes. “We believe our technology can improve the quality of patient care at a lower cost by providing meaningful and timely data to those who need it to make informed clinical decisions anywhere.”
The Diagnotes system was developed in close collaboration with healthcare providers and hospital administrators, and has been piloted in several Indiana-based hospitals and physician group practices.
BioCrossroads (www.biocrossroads.com) is Indiana’s initiative to grow, advance and invest in the life sciences, a public private collaboration that supports the region’s existing research and corporate strengths while encouraging new business development. BioCrossroads provides money and support to life sciences businesses, launches new life sciences enterprises (Indiana Health Information Exchange, Fairbanks Institute for Healthy Communities, BioCrossroadsLINX, and Datalys Center), expands collaboration and partnerships among Indiana’s life science institutions, promotes science education and markets Indiana’s life sciences industry.
About the Indiana Seed Fund II
The $8.25 million, return driven Indiana Seed Fund II was launched in April 2012. Managed by BioCrossroads, the Fund is a follow-on to the $6 million Indiana Seed Fund I. The Fund makes investments up to $1 million in early-stage biotechnology, pharmaceutical, medical device, diagnostic, ag-biotech and health information technology products and platforms.
Diagnotes Inc. is an Indianapolis-based health IT company. Its comprehensive communication system for on-call healthcare providers allows clinicians and patients to connect with on-call providers while simultaneously delivering key patient information from the EHR to the point of care. From the initial inbound call or secure text message through documentation of the completed encounter and support for follow-up actions, Diagnotes seamlessly delivers a fully integrated, closed-loop solution that readily integrates into current clinical practices. Having cleared multiple pilot studies and security audits, the patent-pending product was released in early 2013. For more information about Diagnotes, visit www.diagnotes.com